Showing results (691-700 of 862) with videos related to
Sort By:
Pageof 87
Brain : a Journal of Neurology|October 12, 2010
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's diseaseClifford R Jack, Heather J Wiste, Prashanthi Vemuri, et al.Frontiers in Neuroscience|August 14, 2012
Discovery and Replication of Gene Influences on Brain Structure Using LASSO RegressionOmid Kohannim, Derrek P Hibar, Jason L Stein, et al.Brain : a Journal of Neurology|January 19, 2010
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burdenGil D Rabinovici, Ansgar J Furst, Adi Alkalay, et al.Scientific Reports|December 11, 2021
Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNIRosita Shishegar, Timothy Cox, David Rolls, et al.Neurology|December 3, 2010
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohortS Kim, S Swaminathan, L Shen, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2018
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging InitiativeDallas P Veitch, Michael W Weiner, Paul S Aisen, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 19, 2025
Accelerated Cognitive Decline in Late Life Depression: The Role of Amyloid-β, Cortico-Limbic Volume, and White Matter HyperintensitiesEmma Rhodes, Philip S Insel, Michelle Kassel, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2017
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trialsMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.Neuroimage. Clinical|January 5, 2017
A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severityChristopher G Schwarz, Jeffrey L Gunter, Heather J Wiste, et al.Acta Neuropathologica Communications|November 21, 2013
Clinical and multimodal biomarker correlates of ADNI neuropathological findingsJon B Toledo, Nigel J Cairns, Xiao Da, et al.Pageof 87